| Literature DB >> 35145404 |
Ai-Ping Deng1, Chuan-Zhi Kang1, Li-Ping Kang1, Chao-Geng Lyu1, Wen-Jin Zhang1, Sheng Wang1, Hong-Yang Wang1, Tie-Gui Nan1, Li Zhou1, Lu-Qi Huang1, Zhi-Lai Zhan1, Lan-Ping Guo1.
Abstract
Sulfur Angelicae Dahuricae Radix (Baizhi) is a common medicinal herb in Asian countries. A practical protocol combining metabolomics, pharmacology, and cytotoxicity was developed to comprehensively evaluate the influence of sulfur-fumigation on the quality of Baizhi. Furocoumarins could be transformed into sulfur-containing compounds during the sulfuring process, among which 1 and 3 were purified with relatively high abundance and identified as 3,4-dihydrobyakangelicin-4-sulfonic acid and (4R,12S)-3,4-dihydrooxypeucedanin hydrate-4-sulfonic acid (OXH-S), respectively. OXH-S was found to be an addition product of sulfite and oxypeucedanin hydrate (OXH-N). Then, the cytotoxicity and anti-inflammatory activity of OXH-N, OXH-S, and water extracts of sulfured (extraction-S), and unsulfured Baizhi (extraction-N) were evaluated. OXH-S and extraction-S were less toxic than OXH-N and extraction-N, respectively. A comparison of OXH-N with OXH-S and extraction-N with extraction-S showed no significant differences in anti-inflammatory activity. These results suggest that sulfur fumigation can reduce toxicity and does not influence the anti-inflammatory activity of Baizhi, even after chemical composition changes. The proposed protocol based on marker screening, pharmacology, and safety evaluation provides a scientific basis for the standardization and regulation of sulfured Baizhi and other medical materials.Entities:
Keywords: Angelica dahurica; cytotoxicity; furocoumarin; inflammatory; marker; sulfur-fumigation
Year: 2022 PMID: 35145404 PMCID: PMC8822044 DOI: 10.3389/fphar.2021.799504
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Total ion chromatograms of sulfured and unsulfured Baizhi in negative mode (compounds 1–12 are the significantly different compounds).
FIGURE 2Screening of markers. (A) Principal component analysis; (B) OPLS-DA results of sulfured and unsulfured Baizhi; (C) markers of sulfured and unsulfured Baizhi; (D) structures of the markers.
Markers of sulfured and unsulfured Baizhi.
| No | Primary ID | Formula |
| Factor of change | Average (sulfured) | Average (unsulfured) | Std.Dev (sulfured) | Std.Dev (unsulfured) | Assigned identity | Mass error/ppm |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 11.62_80.9624m/z | C17H20O10S | 0.0000 | >10 000 | 652886.00 | 0.01 | 6356.8047 | 0 | 3,4-dihydrobyakangelicin-4-sulfonic acid | −4.6 |
|
| 19.95_351.0524m/z | C16H16O7S | 0.0003 | >10 000 | 612783.00 | 0.01 | >10 000 | 0 | 3,4-dihydroimperatorin-4- sulfonic acid | −4.3 |
|
| 13.34_386.0645n | C16H18O9S | 0.0004 | −343234400 | 1446250.00 | 0.00 | >10 000 | 0 | (4 | −5.0 |
|
| 19.95_80.9625m/z | C16H16O7S | 0.0003 | −28730986 | 678774.00 | −0.02 | >10 000 | 0 | 3,4-dihydroimperatorin-4 sulfonic acid | −4.3 |
|
| 12.01_386.0646n | C16H18O9S | 0.0022 | −73907176 | 1112960.00 | −0.02 | >10 000 | 0 | 3,4-dihydrooxypeucedanin-3 hydrate sulfonic acid | −0.5 |
|
| 13.33_201.0167m/z | C16H18O9S | 0.0001 | 5,839 | 1956890.00 | 335.17 | >10 000 | 48.5538 | (4 | −0.5 |
|
| 16.84_299.9923m/z | C16H18O8S | 0.0195 | −88216400 | 2172000.00 | −0.02 | >10 000 | 0 | 3-(7-(2-en-3-methylbutoxyl)-6-hydroxy-5-benzofuranyl)-3-sulfopropanoic acid | −5.1 |
|
| 10.47_433.0798m/z | C17H22O11S | 0.0286 | −59905080 | 921477.00 | −0.02 | >10 000 | 0 | 3-(7-(2,3-dihydroxy-3-methylbutoxyl)-6-hydroxy-4-methoxyl-5-benzofuranyl)-3-sulfopropanoic acid | −3.7 |
|
| 12.01_201.0167m/z | C16H18O9S | 0.0014 | 51 | 1607570.00 | 31341.20 | >10 000 | 20065.5 | 3,4-dihydrooxypeucedanin-3 hydrate sulfonic acid | −0.5 |
|
| 20.72_330.2387n | C18H34O5 | 0.0133 | 14 | 258763.00 | 3590640.00 | >10 000 | 1.36E+06 | trihydroxy-octadecenoic acid | −0.8 |
|
| 31.02_383.3513m/z | C24H48O3 | 0.0110 | 12 | 67162.30 | 816443.00 | >10 000 | 289813 | Unknown | −1.2 |
|
| 14.32_540.1839n | C25H32O13 | 0.0000 | 27 | 29367.80 | 804740.00 | >10 000 | 46651.8 | (β- | −0.9 |
|
| 15.20_201.0165m/z | C17H18O9S | 0.0049 | 4 | 1143890.00 | 311903.00 | >10 000 | 72493.3 | dihydrobyakangelicol sulfonic acid | 0.8 |
|
| 13.53_540.1839n | C25H32O13 | 0.0009 | 18 | 48986.50 | 889418.00 | >10 000 | 152424 | iso-(β- | 1.3 |
|
| 20.09–381.0631 | C17H18O8S | 0.0002 | 2,830 | 757924.00 | 267.84 | >10 000 | 251.413 | 3,4-dihydrophellopterin-4-sulfonic acid | −3.4 |
|
| 24.52_296.2327n | C31H47NO4 | 0.0047 | 5 | 349326.00 | 1807520.00 | >10 000 | 405150 | unknown | −1.8 |
|
| 24.21_252.6581n | C35H32N4O9 | 0.0030 | 5 | 841348.00 | 178386.00 | >10 000 | 146522 | unknown | −0.6 |
|
| 0.59_342.1144n | C12H22O11 | 0.0243 | 2 | 2469570.00 | 3659350.00 | >10 000 | 241987 | maltose | −0.9 |
|
| 25.16_595.2891m/z | C32H30O9 | 0.0358 | 8 | 120474.00 | 956978.00 | >10 000 | 433359 | unknown | −0.4 |
|
| 26.19_311.1666m/z | unknown | 0.0836 | 1 | 7185990.00 | 5816610.00 | >10 000 | 411043 | unknown |
FIGURE 3Structure determination of compound 1, 3 and chemical transformation mechanism in sulfuring process. Key heteronuclear multiple bond correlations (HMBCs) of compound 3 (A); Δδ values (Δδ = δS − δR) obtained from the methyl-α-trifluoromethylphenyl lactic acid (MTPA) esters of compound 3 (B); 1H NMR (marked red) and 13C NMR (marked blue) values of compound 1 and compound 3 (C); Chemical transformation mechanism in sulfuring (D).
FIGURE 4Cell growth inhibition rate with each drug based on (A) L02 cells, (B) HK2 cells, and (C) PC12 cells (n = 3; *p < 0.01, **p < 0.05, ***p < 0.001).
FIGURE 5Anti-inflammatory effect evaluation. (A) number of neutrophils in zebrafish yolk sac (n = 10; compared with that in model control group, *p < 0.01, **p < 0.05, ***p < 0.001); (B) inflammatory regression in each group (n = 10).
FIGURE 6Stability of OXH-S and sulfur dioxide residue during the boiling process. (A) Content of OXH-S and sulfur dioxide residue (n = 3); (B) Chemical transformation of OXH-S and sulfite.